Clover Health Investments
CLOV
93 hedge funds and large institutions have $300M invested in Clover Health Investments in 2020 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 66 closing their positions.
0% more funds holding
Funds holding: 93 → 93 (0)
0% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 66
0% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 13
2% less call options, than puts
Call options by funds: $72.9M | Put options by funds: $74.2M
39.64% less ownership
Funds ownership: 61.31% → 21.66% (-40%)
49% less capital invested
Capital invested by funds: $592M → $300M (-$292M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$23.9M |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$21.3M |
| 3 |
BCP
Berylson Capital Partners
Boston,
Massachusetts
|
+$13.3M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$12.1M |
| 5 |
Jane Street
New York
|
+$11.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$67.9M |
| 2 |
SCM
Suvretta Capital Management
New York
|
-$45.8M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$37.4M |
| 4 |
Millennium Management
New York
|
-$36.7M |
| 5 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$33.1M |
CLOV Hedge Fund Activity: Q4 2020 in Review
93 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q4 2020, worth a combined $300M — down 49% from $592M a quarter earlier.
Fund positioning in CLOV was balanced in Q4 2020: 66 funds opened new positions, 66 closed out, 13 added to existing stakes and 13 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $23.9M. The largest seller was Linden Advisors, cutting an estimated $67.9M.
- 93 institutional investors held Clover Health Investments (CLOV) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $300M of Clover Health Investments stock for Q4 2020, down 49% quarter-over-quarter.
- 66 funds opened new Clover Health Investments positions in Q4 2020 and 66 closed out, a net change of 0 holders.
- The largest Clover Health Investments buyer in Q4 2020 was Susquehanna International Group, an estimated $23.9M added.
- The largest Clover Health Investments seller in Q4 2020 was Linden Advisors, an estimated $67.9M sold.
Based on aggregated 13F filings for Q4 2020.